Top 3 UT MD Anderson abstracts at AACR 2026
At the 2026 American Association for Cancer Research (AACR) Annual Meeting, UT MD Anderson experts will showcase their cutting-edge work that impacts patients across the globe.
I’m so proud of all the progress our researchers have made in discovery science and translational research that will be on display. These advancements will bring forth new therapies...
How digital twins are making cancer surgery safer
Surgical procedures are a common part of cancer diagnosis and treatment, from a biopsy to determine the stage and type of cancer to the removal...
New advances in our understanding of cancer metabolism
Metabolism is the process by which the cells in your body use nutrients from the food you eat to get the energy you need.
When...
‘Drug hunter’ deploys AI to accelerate path to new therapies
When Tim Heffernan, Ph.D., arrived at UT MD Anderson in 2011, he saw an opportunity to fundamentally change how cancer drugs are developed. With experience spanning academia and the biopharmaceutical sector, he recognized that the traditional model — years of siloed trial and error — needed transformation.
Heffernan, a self-described “drug hunter,” now leads this change as vice president and head, Oncology Research and Development...
Leveraging lessons from cancer immunotherapy to develop better treatments for autoimmunity
Immunotherapy has transformed cancer treatment, helping countless patients live longer, healthier lives. But researchers are continuing to...
How an electrical engineer is making a big impact on cancer research
Xiling Shen, Ph.D., was an electrical engineering professor when a landmark discovery prompted him to shift the focus of his work and dedicate...
Journal launch enables oncology education and quality improvement
How do you make your work more efficient without reinventing the wheel?
That’s what radiation oncologist Shalin Shah, M.D., was...
18 research advances only possible here
Updated Jan. 27, 2026
From clinical trial results that accelerated Food and Drug Administration (FDA) approval to discovery-based...
4 notable presentations from ASH 2025
MD Anderson researchers are working diligently to transform our understanding of blood cancers and bring the latest cutting-edge therapies...
5 notable presentations from ESMO 2025
The European Society for Medical Oncology (ESMO) Congress brings together international experts for collaborative discussions on every area...